Newly Launched COVID -19 Pneumonia Image Analysis Program

Fujifilm India in association with Sakra World Hospital Bengaluru has initiated new technology in diagnosing chest CT of COVID-19 patients to support India in its fight against the global pandemic - COVID -19.

Fujifilm India Private Limited, a pioneer in imaging technologies has recently joined hands with Bengaluru-based Sakra World Hospital to assist doctors in diagnosing the possibility of COVID-19 pneumonia among patients with the help of new AI-enabled software.

This association has been borne out of Fujifilm India’s campaign “COVID-19 Pneumonia Image Analysis Program” which helps in diagnosing chest CT images of COVID-19 patients.

COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.

‘“COVID-19 Pneumonia Image Analysis Program” helps in diagnosing COVID-19 pneumonia in chest CT images by offering characteristic image findings.’

The COVID-19 -AI-enabled software “COVID-19 Pneumonia Image Analysis Program” by Fujifilm India is a software that has strengthened India’s fight towards COVID-19.

The technology automatically analyses the chest CT images and displays the results which assist doctors in diagnosing COVID-19 pneumonia and ultimately saving human lives.

Additionally, SYNAPSE 3D, a workstation system visualizes and analyzes high-precision 3D images from tomographic images such as CT and MRI by utilizing Fujifilm India’s image recognition technology.

COVID in Children | Guidelines for Management of COVID-19 in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.

The spread of the new Coronavirus infection has been overwhelming in hospitals. So, for better diagnosis of the occurrence of COVID-19 among patients, chest CT is conducted in addition to PCR/Antigen tests at the time of hospitalization or emergencies .

While the burden of these tests is increasing, there is a dire need for solutions that support efficient tests and accurate diagnostic imaging, especially for patients with post-COVID lung management issues.

Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.

Commenting on the association, Mr. Koji Wada, Managing Director, Fujifilm India said, “Fujifilm India has always been committed to bringing innovations in the healthcare sector. Our goal has been to provide the masses with the best medical solutions. We are delighted to join hands with Sakra World Hospital to pave the way for a healthier India. With our new technology, we aim to reduce the burden on the healthcare workers who have been at the forefront in the fight against COVID-19”.

This new AI technology will empower healthcare workers in fighting such complications. Fujifilm India has always contributed and will continue to contribute to making health conditions better in India and ensuring a good lifestyle for its citizens.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

Source-Medindia